Le Lézard
Classified in: Health
Subjects: CCA, PLW, FVT

Clarivate to Report Third Quarter 2020 Results on October 29, 2020


LONDON, Oct. 1, 2020 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the third quarter 2020 before the market opens on Thursday, October 29. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at www.clarivate.com. The Company will host a conference call and webcast on Thursday, October 29 at 8:00 AM Eastern Time to review the results.

The live webcast of the call will be accessible through the investor relations section of the Company's website. To join the webcast please visit https://services.choruscall.com/links/ccc201105.htmlhttps://services.choruscall.com/links/ccc200506.htmlhttps://urldefense.proofpoint.com/v2/url?u=https-3A__services.choruscall.com_links_ccc200227.html&d=DwMFAg&c=OGmtg_3SI10Cogwk-ShFiw&r=gUTuxzUS1UsIb16SBz5wNw-B2Hhn5Mj0GUrJacY2qW4&m=vhXx2ZeRWbZcHd6Muf2C3tGGi51xaUEek2wBWSGU5vs&s=XbYKMcoQknLglZc8kppJyMq1mpiuLK6oQd1bdyBgMF0&e=. A replay will also be available on the investor relations section of the Company's website.

Interested parties may access the live audio broadcast by dialing (888) 317-6003 (in the United States), 412-317-6061 (International) and 866-284-3684 (Canada). The conference ID number is 9584356.

An audio replay will be available approximately two hours after the completion of the call at 877-344-7529 (in the US), 412-371-0088 (International) and 855-669-9658 (Canada). The replay access code is 10139889. The recording will be available for replay through November 12, 2020.

About Clarivate
Clarivatetm is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions. Covering scientific and academic research, pharmaceutical, biotech and healthcare intelligence and intellectual property services, we help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit?clarivate.com.

Category: Earnings
Source: Clarivate Plc

Logo - https://mma.prnewswire.com/media/1159266/Clarivate_Analytics.jpg


These press releases may also interest you

7 mai 2024
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...

7 mai 2024
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...

7 mai 2024
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...

7 mai 2024
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO). An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...

7 mai 2024
Mexico's pharmaceutical and personal care industry is undergoing significant changes with the strategic moves announced by Genomma Lab International, S.A.B. de C.V. (B.M.V.: LABB) regarding its agreement to redeem capital in Marzam. The...

7 mai 2024
Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES The updated release reads: ZYUS LIFE SCIENCES CORPORATION TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE MAY 8-9 NOT FOR...



News published on and distributed by: